Group 1 - The company Zhejiang Haizheng Biomaterials Co., Ltd. has approved a share repurchase plan to buy back its A-shares using its own funds, with a maximum price of RMB 12.00 per share and a total repurchase amount between RMB 20 million and RMB 30 million [2] - The repurchase period is set for a maximum of 12 months from the date of board approval, which is August 28, 2024 [2] - As of October 31, 2025, the company has repurchased a total of 1,900,000 shares, accounting for 0.937% of the total share capital, with a total expenditure of approximately RMB 20.49 million [2][5] Group 2 - The company adjusted the source of repurchase funds from "own funds" to include "own funds and special loans for stock repurchase" as of March 11, 2025 [2] - The maximum repurchase price was later increased to RMB 17.00 per share, and the repurchase period was extended by 6 months to February 27, 2026 [2] - The highest and lowest prices for the repurchased shares were RMB 15.98 and RMB 7.76 per share, respectively [2] Group 3 - On November 3, 2025, the company received a notice from its shareholder, Sinopec Group Capital Co., Ltd., regarding a reduction in shareholding [6] - Sinopec Group Capital reduced its holdings by 783,484 shares, bringing its total shares down to 12,031,410, which is 5.94% of the total share capital [6][7] - This reduction is part of a previously disclosed share reduction plan and will not affect the company's controlling shareholder or its governance structure [7][8]
浙江海正生物材料股份有限公司关于股份回购进展公告